Asthma heterogeneity and severity
Asthma is a common, chronic inflammatory airways disease characterized by a clinical syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow obstruction. Individuals with asthma can vary widely in clinical presentation, severity, and pathobiology. The incident factors, pathog...
Main Authors: | Tara F. Carr, Eugene Bleecker |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119301966 |
Similar Items
-
Biomarkers for severe eosinophilic asthma.
by: Yancey, S, et al.
Published: (2017) -
Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
by: Yancey, S, et al.
Published: (2016) -
Is it severe asthma or asthma with severe comorbidities?
by: Brussino L, et al.
Published: (2017-11-01) -
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
by: Pavord, I, et al.
Published: (2012) -
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
by: Anne-Noelle Frix, et al.
Published: (2022-10-01)